Questions discussed in this category
How has this impacted your counseling and management?
Are you less likely to prescribe it for patients with dyslipidemia or autoimmune disease?
Patient previously failed abatacept and Rituximab.
Would the etiology of the thrombocytosis play a role in your decision-making?
2087619401161891723317645146131607014641136358311
Papers discussed in this category
Arthritis & rheumatology (Hoboken, N.J.), 2016-11
Annals of the rheumatic diseases, 2019-04
Journal for immunotherapy of cancer, 2022 Jan
Clinical rheumatology, 2020 Sep 28
Frontiers in immunology, 2022 Sep 15
Cancer cell, 2022 May 09
Annals of the rheumatic diseases, 2023 May 29
Arthritis & rheumatology (Hoboken, N.J.), 2017-03
Annals of the rheumatic diseases, 2019 Jul 30
N Engl J Med,
Autoimmunity reviews, 2023 Dec 20